oxymatrine has been researched along with Alzheimer Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Sun, J; Tian, J; Wang, Z; Zhao, Y; Zhi, Z | 1 |
| Gao, C; Sui, R; Wang, Z; Zhang, L; Zhu, Y | 1 |
| Cao, XK; Dong, PL; Han, H; Li, Z; Teng, CL; Yin, X | 1 |
| Dong, P; Han, H; Han, W; Ji, X | 1 |
| Chen, Y; Hao, Y; Li, H; Lv, Z; Qi, Z; Qiao, B | 1 |
5 other study(ies) available for oxymatrine and Alzheimer Disease
| Article | Year |
|---|---|
Targeting the TLR4/NF-κB pathway in β-amyloid-stimulated microglial cells: A possible mechanism that oxysophoridine exerts anti-oxidative and anti-inflammatory effects in an in vitro model of Alzheimer's disease.
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; Interleukin-1beta; Mice; Microglia; NF-kappa B; Oxidative Stress; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2021 |
Oxymatrine-mediated prevention of amyloid β-peptide-induced apoptosis on Alzheimer's model PC12 cells: in vitro cell culture studies and in vivo cognitive assessment in rats.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Culture Techniques; Cognition; Humans; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Rats | 2023 |
Synthesis and evolution of neuroprotective effects of oxymatrine derivatives as anti-Alzheimer's disease agents.
Topics: Alkaloids; Alzheimer Disease; Animals; Cell Survival; Drug Discovery; Humans; Inflammation; Interleukin-1beta; Microglia; Neurons; Neuroprotective Agents; PC12 Cells; Quinolizines; Rats; Small Molecule Libraries; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2021 |
Oxymatrine attenuates amyloid beta 42 (Aβ
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cells, Cultured; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Male; Maze Learning; Memory; Neurons; Oxidative Stress; Peptide Fragments; Primary Cell Culture; Quinolizines; Rats; Rats, Sprague-Dawley | 2019 |
Oxymatrine can attenuate pathological deficits of Alzheimer's disease mice through regulation of neuroinflammation.
Topics: Alkaloids; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Inflammation Mediators; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Quinolizines | 2019 |